Company News, Marketing News

Innocan Pharma Announces 5,000 Units Sale and Expansion to Lithuania, Latvia & Estonia Markets

Per the multi-year agreement, UAB Medexy has an exclusive right to distribute both Innocan's SHIR and RELIEF&GO brands on an agreed purchase forecast.

Author Image

By: Lianna Albrizio

Associate Editor

Innocan Pharma Corporation has entered into of a wide-scope commercial distribution agreement with UAB Medexy.   Per the multi-year agreement, UAB Medexy has an exclusive right to distribute both Innocan's SHIR and RELIEF&GO brands in Lithuania, Latvia & Estonia, based on an agreed purchase forecast.   UAB Medexy's first order under the agreement is for over 5,000 units of SHIR and RELIEF&GO products. A Key Eastern European Player in the Import and Di...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters